scholarly journals Written exposure therapy for posttraumatic stress symptoms and suicide risk: Design and methodology of a randomized controlled trial with patients on a military psychiatric inpatient unit

2021 ◽  
pp. 106564
Author(s):  
Brian P. Marx ◽  
Brooke A. Fina ◽  
Denise M. Sloan ◽  
Stacey Young-McCaughan ◽  
Katherine A. Dondanville ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Posttraumatic Stress ◽  
Suicide Risk ◽  
Controlled Trial ◽  
Psychiatric Inpatient ◽  
Inpatient Unit ◽  
Posttraumatic Stress Symptoms ◽  
Randomized Controlled ◽  
Stress Symptoms ◽  
Psychiatric Inpatient Unit

scholarly journals EMDR Protocol for Recent Critical Incidents: A Randomized Controlled Trial in a Technological Disaster Context

2015 ◽  
Vol 9 (4) ◽  
pp. 166-173 ◽  
Author(s):  
Ignacio Jarero ◽  
Susana Uribe ◽  
Lucina Artigas ◽  
Martha Givaudan
Keyword(s):  
Randomized Controlled Trial ◽  
Posttraumatic Stress ◽  
Critical Incident ◽  
Critical Incidents ◽  
Controlled Trial ◽  
Posttraumatic Stress Symptoms ◽  
Technological Disaster ◽  
Randomized Controlled ◽  
Stress Symptoms ◽  
Treatment Conditions

This research evaluated the effectiveness of the Eye Movement Desensitization and Reprocessing (EMDR) Protocol for Recent Critical Incidents (EMDR-PRECI) in reducing posttraumatic stress symptoms related to the explosion in an explosives manufacturing factory north of Mexico City that killed 7 employees. The EMDR-PRECI was administered on 2 consecutive days to 25 survivors who had posttraumatic stress symptoms related to the critical incident. Participants’ mean score on the Short PTSD Rating Interview (SPRINT) was 22, well above the clinical cutoff of 14. They were randomly assigned to immediate and waitlist/delayed treatment conditions and therapy was provided within 15 days of the explosion. Results showed significant main effects for the condition factor, F(1, 80) = 67.04, p < .000. SPRINT scores were significantly different across time showing the effects of the EMDR therapy through time, F(3, 80) = 150.69, p < .000. There was also a significant interaction effect, condition by time, F(2, 80) = 55.45, p < .001. There were significant differences between the two treatment conditions at Time 2 (post-immediate treatment vs. post-waitlist/delayed), t(11) = −10.08, p < .000. Treatment effects were maintained at 90-day follow-up. Results also showed an overall subjective improvement in the participants. This randomized controlled trial provides evidence for the efficacy of EMDR-PRECI in reducing posttraumatic stress symptoms after a technological disaster.

scholarly journals A pragmatic effectiveness randomized controlled trial of duration of psychiatric hospitalization in a trans-diagnostic sample of patients with acute mental illness admitted to a ward with either blue depleted evening lighting or normal lighting conditions

2019 ◽  
Author(s):  
Jan Scott ◽  
Knut Langsrud ◽  
Daniel Vethe ◽  
Kaia Kjørstad ◽  
Cecilie Lund Vestergaard ◽  
...  
Keyword(s):  
Light Exposure ◽  
Controlled Trial ◽  
Psychiatric Inpatient ◽  
Well Being ◽  
Acute Illness ◽  
Inpatient Unit ◽  
Illness Episode ◽  
Randomized Controlled ◽  
Lighting Conditions ◽  
Psychiatric Inpatient Unit

Abstract Introduction There is increasing recognition of the need to stabilize sleep-wake cycles in individuals with major mental disorders. As such, clinicians and researchers advocate for the use of interventions targeted at sleep and circadian dysrhythmias as an adjunct to the standard treatments offered for acute illness episodes of a broad range of diagnoses. To determine the trans-diagnostic generalizability of chronotherapy, we explore the benefits of admitting individuals with an acute illness episode to a psychiatric inpatient unit where changes in light exposure are integrated into the therapeutic environment. Methods A two-arm pragmatic effectiveness randomized controlled treatment trial, where individuals admitted for acute inpatient psychiatric care will be allocated to a ward with blue depleted evening light or to a ward with the same layout and facilities but lacking the new lighting technology. The trial will test whether the experimental lighting conditions offer any additional benefits beyond those associated with usual treatment in an acute psychiatric inpatient unit. The main objectives are to examine any differences between groups in the mean duration of hospitalization in days. Additional analyses will compare group differences in symptoms, functioning, medication usage, and side-effects and whether length of stay is associated with stability of sleep-wake cycles and circadian rhythms. Ancillary investigations will determine any benefits according to diagnostic subgroups and potential drawbacks such as any adverse effects on the well-being of professionals working across both wards. Discussion This unit offers a unique opportunity to explore how exposure to different lighting conditions may modify sleep-wake cycles and how any changes in sleep-wake cycle may impact on the clinical and functional outcomes of individuals experiencing an acute episode of a severe mental disorder that requires inpatient care. The findings could influence the future design of hospital units offering care to patients with mental or physical disorders. Trial registration Clinicaltrials.gov NCT03788993, retrospectively registered Dec 28th 2018. https://clinicaltrials.gov/ct2/show/NCT03788993.

scholarly journals A pragmatic effectiveness randomized controlled trial of duration of psychiatric hospitalization in a trans-diagnostic sample of patients with acute mental illness admitted to a ward with either blue depleted evening lighting or normal lighting conditions

2019 ◽  
Author(s):  
Jan Scott ◽  
Knut Langsrud ◽  
Daniel Vethe ◽  
Kaia Kjørstad ◽  
Cecilie Lund Vestergaard ◽  
...  
Keyword(s):  
Light Exposure ◽  
Controlled Trial ◽  
Psychiatric Inpatient ◽  
Well Being ◽  
Acute Illness ◽  
Inpatient Unit ◽  
Illness Episode ◽  
Randomized Controlled ◽  
Lighting Conditions ◽  
Psychiatric Inpatient Unit

Abstract Introduction There is increasing recognition of the need to stabilize sleep-wake cycles in individuals with major mental disorders. As such, clinicians and researchers advocate for the use of interventions targeted at sleep and circadian dysrhythmias as an adjunct to the standard treatments offered for acute illness episodes of a broad range of diagnoses. To determine the trans-diagnostic generalizability of chronotherapy, we explore the benefits of admitting individuals with an acute illness episode to a psychiatric inpatient unit where changes in light exposure are integrated into the therapeutic environment. Methods A two-arm pragmatic effectiveness randomized controlled treatment trial, where individuals admitted for acute inpatient psychiatric care will be allocated to a ward with blue depleted evening light or to a ward with the same layout and facilities but lacking the new lighting technology. The trial will test whether the experimental lighting conditions offer any additional benefits beyond those associated with usual treatment in an acute psychiatric inpatient unit. The main objectives are to examine any differences between groups in the mean duration of hospitalization in days. Additional analyses will compare group differences in symptoms, functioning, medication usage, and side-effects and whether length of stay is associated with stability of sleep-wake cycles and circadian rhythms. Ancillary investigations will determine any benefits according to diagnostic subgroups and potential drawbacks such as any adverse effects on the well-being of professionals working across both wards. Discussion This unit offers a unique opportunity to explore how exposure to different lighting conditions may modify sleep-wake cycles and how any changes in sleep-wake cycle may impact on the clinical and functional outcomes of individuals experiencing an acute episode of a severe mental disorder that requires inpatient care. The findings could influence the future design of hospital units offering care to patients with mental or physical disorders. Trial registration Clinicaltrials.gov NCT03788993, retrospectively registered Dec 28th 2018. https://clinicaltrials.gov/ct2/show/NCT03788993.

Sign in / Sign up

Export Citation Format

Share Document